Author:
Gholami Ali,Karami Esmail,Ebrahimpoorghalehjoghi Sahar,Hajjarzadeh Mehrab,Javadi Kasra,Bakhtiari Mehran,Mahjoor Mohamad,Rad Fatemeh,Mehboodi Mahtab,Mottaghiyan Zahra,Akhavan-Sigari Reza
Reference162 articles.
1. Lindequist U, Niedermeyer TH, Jülich W-D. The pharmacological potential of mushrooms. Evidence-Based Complementary and Alternative Medicine. 2005;2(3):285-99.
2. Wasser SP. Current findings, future trends, and unsolved problems in studies of medicinal mushrooms. Applied microbiology and biotechnology. 2011;89(5):1323-32.
3. Wu G-S, Lu J-J, Guo J-J, Li Y-B, Tan W, Dang Y-Y, et al. Ganoderic acid DM, a natural triterpenoid, induces DNA damage, G1 cell cycle arrest and apoptosis in human breast cancer cells. Fitoterapia. 2012;83(2):408-14.
4. Radwan FF, Perez JM, Haque A. Apoptotic and immune restoration effects of ganoderic acids define a new prospective for complementary treatment of cancer. Journal of clinical & cellular immunology. 2011:004.
5. Bishop KS, Kao CH, Xu Y, Glucina MP, Paterson RRM, Ferguson LR. From 2000 years of Ganoderma lucidum to recent developments in nutraceuticals. Phytochemistry. 2015;114:56-65.